RNS Number : 7100B
12 October 2020


Update Regarding Debt Financing


AVEVA Group plc ('AVEVA'), a global leader in engineering and industrial software, is pleased to provide an update on the debt financing relating to its proposed acquisition of OSIsoft announced on 25 August 2020.


Syndication of the £250 million revolving credit facility has now successfully completed with HSBC and Santander joining J.P. Morgan, Barclays and BNP Paribas (the 'Debt Underwriters') as providers of this facility.


As regards the proposed $900 million term loan (the 'Term Loan'), the independent board of AVEVA has reached agreement with Schneider Electric and the Debt Underwriters that the Term Loan will not now proceed to syndication, but will instead be provided directly to AVEVA by Schneider Electric (the 'SE Term Loan') on terms which are identical in all material respects to those originally envisaged, save that:


i.      the interest margin will be improved versus that previously envisaged at all leverage levels; and,


ii.     AVEVA will not now incur lenders' participation fees.


The SE Term Loan will still have a 3-year term and is pre-payable at any time without penalty, in whole or in part, at AVEVA's option.


The timetable for the proposed acquisition of OSIsoft remains on track. Publication of the Circular and Prospectus to approve the transaction and launch the proposed rights issue is expected in early November 2020.





AVEVA Group plc

Matthew Springett, Head of Investor Relations: +44 (0) 1223 556 676


FTI Consulting LLP

Edward Bridges / Dwight Burden: +44 (0) 203 727 1000


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.